SCHEMBL12366339

SCHEMBL12366339

[C-]#[N+]c1c(C(F)(F)F)cc(-c2cccc(C)c2)n(Cc2ccccc2Cl)c1=O

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.42
MAPT P10636 2/20 0.42
KDM4E B2RXH2 2/20 0.42
SLC16A3 O15427 3/20 0.41
SLC16A1 P53985 3/20 0.41
MCTS1 Q9ULC4 3/20 0.41
ORAI1 Q96D31 1/20 0.38
PTGER3 P43115 1/20 0.36
NR1H2 P55055 3/20 0.36
NR1H3 Q13133 3/20 0.36
LMNA P02545 1/20 0.35
RXRA P19793 1/20 0.35
EPHX2 P34913 1/20 0.35
PPARG P37231 1/20 0.35
OPRK1 P41145 1/20 0.35
ITGB1 P05556 1/20 0.35
ITGA4 P13612 1/20 0.35
ITGB7 P26010 1/20 0.35
MEN1 O00255 2/20 0.34
KMT2A Q03164 2/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12366281 0.91 MDM2 (0.40) ALDH1A1KDM4ENR1H2NR1H3RXRA
SCHEMBL12366459 0.90 KDM4E (0.43) ALDH1A1MAPTKDM4ESLC16A3SLC16A1
SCHEMBL12366246 0.90 GAA (0.39) ALDH1A1KDM4ENR1H2NR1H3LMNA
SCHEMBL12366315 0.90 ALDH1A1 (0.48) ALDH1A1MAPTKDM4ESLC16A3SLC16A1
SCHEMBL12366328 0.89 NR1H2 (0.41) ALDH1A1MAPTKDM4ENR1H2NR1H3
SCHEMBL12366467 0.88 RXRA (0.37) SLC16A3SLC16A1MCTS1ORAI1NR1H2
SCHEMBL12366233 0.88 CNR1 (0.42) ALDH1A1MAPTKDM4EITGB1ITGA4
SCHEMBL12366504 0.87 MCL1 (0.37) ALDH1A1NR1H2NR1H3RXRAKMT2A
SCHEMBL12366461 0.87 CMA1 (0.35) NR1H2NR1H3RXRACYP3A4CYP2C9
SCHEMBL12366413 0.87 NR1H2 (0.36) ALDH1A1MAPTKDM4ENR1H2NR1H3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7998986-B2 Heterocyclic compounds, in particular N-substituted pyridones for modulating the activity of nuclear receptors EXELIXIS PATENT COMPANY LLC (US) 2011-08-16 US disclosed